Gardasil, a vaccine against human papilloma virus (HPV), has been approved as a treatment to prevent genital warts in males aged nine to 26 in Canada, the vaccine's manufacturer said Tuesday.
Read the full story on www.cbc.ca
|
Print This Page |
|
Gardasil, a vaccine against human papilloma virus (HPV), has been approved as a treatment to prevent genital warts in males aged nine to 26 in Canada, the vaccine's manufacturer said Tuesday.
Read the full story on www.cbc.ca |
|